Cellebrite DI Ltd. (CLBT)
| Previous close | 10.85 |
| Open | 10.92 |
| Bid | 10.78 x 100 |
| Ask | 10.85 x 100 |
| Day's range | 10.77 - 10.93 |
| 52-week range | 5.22 - 12.50 |
| Volume | |
| Avg. volume | 961,659 |
| Market cap | 2.219B |
| Beta (5Y monthly) | 1.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2024 financial results before market open on Thursday, May 23, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2024 and discuss its 2024 outlook
- GlobeNewswire
Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership
Appointment Builds on the Momentum Behind Cellebrite’s Preeminent Case-to-Closure Platform and Market-Leading Investigative Solutions to Accelerate Justice David Gee, Cellebrite Chief Marketing Officer David Gee was appointed Chief Marketing Officer at Cellebrite. TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 25, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd (Nasdaq: CLBT), a global leader in Digital Investigative solutions for the public and private sectors, today announced the appointment of
- GlobeNewswire
Cellebrite Files its 2023 Annual Report on Form 20-F
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2023, with the U.S. Securities and Exchange Commission (the “SEC”). Cellebrite’s 2023 Annual Report on Form 20-F is available on the investor relations section of its website at https://invest
